Wereport a nephrotic syndrome patient with eosinophilia who developed ileus, epigastralgia and malabsorption due to strongyloidiasis which became symptomatic by steroid therapy. The patient was then treated with thiabendazole and recovered. A percutaneous renal biopsy revealed minimal change nephrotic syndrome. This renal injury may be brought on by severe infection of Strongyloides stercoralis. It is important to rule out strongyloidiasis prior to corticosteroid therapy to patients from eosinophilia endemicareas. (Internal Medicine 37: 606-610, 1998) 
Introduction
Strongyloidiasis is a knowndisease in tropical areas; Amami and Okinawaare endemic areas in Japan. A study reported that in Okinawaprefecture Strongyloides stercoralis infection is observed in six percent of the inhabitants (1 A percutaneous renal biopsy was performed on the 7th hospital day. Light microscopic findings of the biopsy specimen ( Fig. 1 ) , which contained six glomeruli, revealed moderate segmental focal expansion of the mesangial matrix with no mesangial cell proliferation. A few oftubules were damaged by mainly monocytic infiltration following necrosis. There was, glutamic oxaloacetic transaminase, GPT: glutamic pyruvic transaminase, LDH: lactate dehydrogenase, BUN:blood urea nitrogen.
however, no eosinophilic infiltration.
In the immunofluorescence stain, immunoglobulin M(IgM) was positive in the mesangium lesion. Immunoglobulin A (IgA), immunoglobulin G (IgG) and fibrinogen were negative. The diagnosis of minimal change nephrotic syndromewas madeand steroid therapy was started. Treatment with 40 mgof prednisolone was started, and proteinuria decreased to 0.5 g/day 21 days later. Although there was improvement of the edema, his weight further decreased to 60 kg and he became thin. On the 41st hospital day the patient developed vomiting, abdominal distension and epigastralgia. The bowel sound was hypoactive. An abdominal X-ray showed an abnormal gas collection in the large and small bowels with niveau ( Fig. 2) . With the diagnosis of paralytic ileus, fasting and continuous suction by nasogastric tube were begun. Following nasogastric suction for 2 days, ileus improved, but epigastralgia continued. Since gastric ulcer was suspected, gastrointestinal fiberscope was performed. Endoscopic findings were erosion of the middle and lower esophagus, bleeding points of stomach body and prepylorus, and edematous lesion of the posterior wall of duodenum. Biopsy specimen showednumerousstrongyloides larvae and eggs in the crypt wall of prepylorus mucosa and edematous lesion of duodenum (Fig.3) .
The stool showed a large number of moving strongyloides larvae, and eggs. There were 85,000 larvae per 1 g stool. Filter paper cultured filariform larva had a forked tail-end (Fig. 4) , and we regarded this roundwormas Strongyloides stercoralis.
Thiabendazole 3 g/day was started with the improvement of epigastralgia. On the following day (5th day), no larva was seen in the stools. Abdominal distension disappeared by the 7th day of thiabendazole therapy. The patient' s weight returned to 65 kg.
With achievement of the control of proteinuria 0.4-0.2 g/ day, he was discharged with prednisolone (20 mg/day). After discharge, occasional larva was seen in the stool but subsided after repeated thiabendazole therapy.
Discussion
The body length of Strongyloides stercoralis is 2.5 mmin imago, and 0.3 to 0.6 mmin larva. The clinical importance of Strongyloides stercoralis infection depends in part on defining its life-cycle, which is the most complex of all nematodes that parasitize the intestinal tract ofhumans. In this form of the lifecycle the rhabditiform larvae change to the infective filariform type in the gut lumen and pass via the gut wall and the local lymphatis to the blood-stream, invade the liver, and migrate to the lung. Eggs buried in the mucosa, hatch into rhabditiform larvae. Commonlyinfected by contact or ingestion of contami- Diagnosis of strongyloidiasis is confirmed by the presence of the larvae in the stool or duodenal aspirate. Duodenal biopsy usually shows invasion by the parasite and ova with blunting of Although Thiabendazole is very effective against Strongyloides stercoralis, the incidence of severe side effects is extremely high. In this case, loss of appetite and severe general fatigue were observed. However,these symptomswere temporary and not major clinical problems. Shinkawa et al reported the useful method of a 2-course thiabendazole therapy without recurrence (4). Shikiya and colleagues reported that lvermectin might be useful and relatively safe for the therapy of Strongyloides stercoralis infection as an alternative to thiabendazole (5) .
Marked eosinophilia of this patient on admission was considered as Strongyloides stercoralis infection. High percentage of eosinophils are compatible with hyperinfection syndrome. If all patients (compromised and non compromised) are considered, higher eosinophil counts (>8%) are associated with a better prognosis (6) . In contrast, eosinopenia shows a poor prognosis in patients with strongyloidiasis (7). The lack of hypercholesterolemia and the low serum urea nitrogen due to malabsorption also suggested Strongyloides stercoralis infection in this case.
Okinawa is an human T-cell leukemia virus type-I (HTLV-I) endemic area as well. Nakada et al reported 39%of patients with Strongyloides stercoralis were positive of HTLV-Iproviral DNA,and supposed that Strongyloides stercoralis and HTLV-I-infected cells or HTLV-I itself may interfere with each other, and the depressed cell-mediated immunity due to HTLV-I allows the development of hyperinfestation of Strongyloides stercoralis (8) . This patient was also sero-positive for HTLV-I.
The cellular immunodeficient state, such as malignant lymphoma, is considered to allow fatal strongyloidiasis (9). But there is no report of hyperinfestation of Strongyloides ste rco ralis in acquired immunodeficiency syndrome (AIDS) patients.
There are somereports on patients with strongyloidiasis associated with nephrotic syndrome (10, 1 1). There was a close relationship between the administration of a fresh course of steroid therapy and the onset of the steatorrhoea. Corticosteroid therapy, leading to the decrease of inflammatory and immunologic responses, may play an important role in the sudden exacerbation of strongyloidiasis ( 1 2). Therefore, here, on diagnosing strongyloidiasis, we immediately treated the patient with thiabendazole and were able to successfully cure strongyloidiasis without reducing the steroid dose.
It has been reported that Strongyloides stercoralis itself usually does not cause any renal injury except for systemic infection (13). In this case it can not be denied that minimal change nephrotic syndrome may be induced by systemic Strongyloides stercoralis infection. Weconclude that the malabsorption in this patient was caused by a change in the host-parasite relationship in favour of the parasite, induced by the steroid therapy. It is very important that the clinician be aware of the possibility of Strongyloides stercoralis infection in patients from endemic areas whoexperience gastrointestinal symptoms, especially if they are receiving steroids.
